3-Hydroxyisobutyric aciduria

Not yet reviewed

This information is AI generated and has not yet been reviewed by a specialist physician. AI can make mistakes.

Disease overview

Rare metabolic condition in which the body is unable to breakdown certain amino acids, caused by changes in the ALDH6A1 gene and inherited in an autosomal recessive manner.

Common symptoms

Developmental delaycharacteristic facial features (Long philtrumMicrotiaTriangular faceMicrognathia) and brain abnormalities (Aplasia/Hypoplasia of the cerebellumAplasia/Hypoplasia of the corpus callosumCerebral calcificationCerebral cortical atrophy)

When to suspect

  • Recommendation 1

    The diagnosis of 3-hydroxyisobutyric aciduria was made by gas chromatography/mass spectrometry analysis

How to test

  • Recommendation 1

    The diagnosis of 3-hydroxyisobutyric aciduria was made by gas chromatography/mass spectrometry analysis

ZebraMD is partnering with Ambry Genetics for clinical-grade whole genome testing for rare diseases. Ambry accepts insurance. If you don’t have a physician to order this test, join our referral list and our team will reach out.

Treatment

  • Recommendation 1

    Limited evidence to support the effectiveness of treatment, but a protein-restricted diet and carnitine supplementation have been tried with varying degrees of success.

Primary care

  • Recommendation 1

    Dietary restriction and dietary adherence

Further support

  • Recommendation 1

    No specific physicians specialize in this condition but NORD recommends various rare disease clinics. Referral to Medical Genetics Department, if available. Initial virtual care is also available through organizations like TeleRare Health.

Clinical trials

Clinical Trials

Sources

No data available

Interested in learning more about 3-Hydroxyisobutyric aciduria?

Follow to receive regular updates to the latest research development on this disease via email newsletter.